AngioDynamics to Participate At Upcoming Investor Conferences

September 9, 2010 at 7:30 AM EDT

ALBANY, N.Y., Sep 09, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, today announced that management will present at upcoming investor conferences during the month of September 2010.

Stifel Nicolaus 2010 Healthcare Conference

Jan Keltjens, AngioDynamics' President and Chief Executive Officer, is scheduled to present at 3:15 p.m. ET on Thursday, Sept. 16, 2010, at the Stifel Nicolaus 2010 Healthcare Conference in Boston, Mass.

CL King 8th Annual Best Ideas Conference

Joseph Gersuk, AngioDynamics' Executive Vice President and Chief Financial Officer, is scheduled to present at 2:45p.m. ET on Thursday, Sept. 16, 2010, at the CL King 8th Annual Best Ideas Conference in New York, N.Y.

Management will review the company's business strategy and recent corporate developments. Attendance at these conferences is by invitation only. Individuals can listen to the live and archived presentations on the Internet by visiting the investor relations portion of the Company's Web site at: http://investors.angiodynamics.com. The archived presentations will be available for 90 days.

About AngioDynamics

AngioDynamics is a leading provider of innovative medical devices used by interventional radiologists, surgeons and other physicians for the minimally-invasive treatment of cancer and peripheral vascular disease. The Company's diverse product line includes market-leading radiofrequency and irreversible electroporation ablation systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. More information is available at www.angiodynamics.com.

SOURCE: AngioDynamics, Inc.

Company Contact:
AngioDynamics, Inc.
D. Joseph Gersuk, CFO, (800) 772-6446 x1608
jgersuk@AngioDynamics.com
or
Investor Relations Contacts:
EVC Group, Inc.
Doug Sherk / Greg Gin, 415-896-6820
dsherk@evcgroup.com
ggin@evcgroup.com
or
Media Contact:
EVC Group, Inc.
Chris Gale, 646-201-5431
cgale@evcgroup.com

Copyright Business Wire 2010